Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial.

Emergency (Tehran, Iran)

Shojaee M, Feizi B, Miri R, Etemadi J, Feizi AH.
PMID: 28286836
Emerg (Tehran). 2017;5(1):e29. Epub 2017 Jan 10.

INTRODUCTION: Treatment of rapid ventricular response arterial fibrillation (rapid AF) varies depending on the decision of the in-charge physician, condition of the patient, availability of the drug, and the treatment protocol of the hospital. The present study was designed...

Cite
Shojaee M, Feizi B, Miri R, et al. Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial. Emerg (Tehran). 2017;5(1):e29
Shojaee, M., Feizi, B., Miri, R., Etemadi, J., & Feizi, A. H. (2017). Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial. Emergency (Tehran, Iran), 5(1), e29.
Shojaee, Majid, et al. "Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial." Emergency (Tehran, Iran) vol. 5,1 (2017): e29.
Shojaee M, Feizi B, Miri R, Etemadi J, Feizi AH. Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial. Emerg (Tehran). 2017;5(1):e29. Epub 2017 Jan 10. PMID: 28286836; PMCID: PMC5325898.
Copy Download .nbib Format: NLM
Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models.

Frontiers in cardiovascular medicine

Sattler SM, Skibsbye L, Linz D, Lubberding AF, Tfelt-Hansen J, Jespersen T.
PMID: 31750317
Front Cardiovasc Med. 2019 Nov 05;6:158. doi: 10.3389/fcvm.2019.00158. eCollection 2019.

Ventricular arrhythmia and subsequent sudden cardiac death (SCD) due to acute myocardial infarction (AMI) is one of the most frequent causes of death in humans. Lethal ventricular arrhythmias like ventricular fibrillation (VF) prior to hospitalization have been reported to...

Cite
Sattler SM, Skibsbye L, Linz D, et al. Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models. Front Cardiovasc Med. 2019;6:158doi: 10.3389/fcvm.2019.00158.
Sattler, S. M., Skibsbye, L., Linz, D., Lubberding, A. F., Tfelt-Hansen, J., & Jespersen, T. (2019). Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models. Frontiers in cardiovascular medicine, 6158. https://doi.org/10.3389/fcvm.2019.00158
Sattler, Stefan Michael, et al. "Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models." Frontiers in cardiovascular medicine vol. 6 (2019): 158. doi: https://doi.org/10.3389/fcvm.2019.00158
Sattler SM, Skibsbye L, Linz D, Lubberding AF, Tfelt-Hansen J, Jespersen T. Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models. Front Cardiovasc Med. 2019 Nov 05;6:158. doi: 10.3389/fcvm.2019.00158. eCollection 2019. PMID: 31750317; PMCID: PMC6848060.
Copy Download .nbib Format: NLM
Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.

Circulation

Rillig A, Magnussen C, Ozga AK, Suling A, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Gulizia M, Haegeli L, Heidbuchel H, Kuck KH, Ng A, Szumowski L, van Gelder I, Wegscheider K, Kirchhof P.
PMID: 34328366
Circulation. 2021 Sep 14;144(11):845-858. doi: 10.1161/CIRCULATIONAHA.121.056323. Epub 2021 Jul 30.

BACKGROUND: Even on optimal therapy, many patients with heart failure and atrial fibrillation experience cardiovascular complications. Additional treatments are needed to reduce these events, especially in patients with heart failure and preserved left ventricular ejection fraction.METHODS: This prespecified subanalysis...

Cite
Rillig A, Magnussen C, Ozga AK, et al. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure. Circulation. 2021;144(11):845-858doi: 10.1161/CIRCULATIONAHA.121.056323.
Rillig, A., Magnussen, C., Ozga, A. K., Suling, A., Brandes, A., Breithardt, G., Camm, A. J., Crijns, H. J. G. M., Eckardt, L., Elvan, A., Goette, A., Gulizia, M., Haegeli, L., Heidbuchel, H., Kuck, K. H., Ng, A., Szumowski, L., van Gelder, I., Wegscheider, K., & Kirchhof, P. (2021). Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure. Circulation, 144(11), 845-858. https://doi.org/10.1161/CIRCULATIONAHA.121.056323
Rillig, Andreas, et al. "Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure." Circulation vol. 144,11 (2021): 845-858. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056323
Rillig A, Magnussen C, Ozga AK, Suling A, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Gulizia M, Haegeli L, Heidbuchel H, Kuck KH, Ng A, Szumowski L, van Gelder I, Wegscheider K, Kirchhof P. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure. Circulation. 2021 Sep 14;144(11):845-858. doi: 10.1161/CIRCULATIONAHA.121.056323. Epub 2021 Jul 30. PMID: 34328366; PMCID: PMC8456351.
Copy Download .nbib Format: NLM
Influence of baseline QTc on sotalol-induced prolongation of ventricular repolarization in men and women.

British journal of clinical pharmacology

Funck-Brentano C, Salem JE.
PMID: 34921433
Br J Clin Pharmacol. 2021 Dec 17; doi: 10.1111/bcp.15188. Epub 2021 Dec 17.

The extent of sotalol-induced QTc prolongation on the electrocardiogram, is variable among subjects and influenced by sex. However, the influence of baseline QTc on the extent of drug-induced QTc prolongation remains unclear. This was studied around peak plasma concentration...

Cite
Funck-Brentano C, Salem JE. Influence of baseline QTc on sotalol-induced prolongation of ventricular repolarization in men and women. Br J Clin Pharmacol. 2021;doi: 10.1111/bcp.15188.
Funck-Brentano, C., & Salem, J. E. (2021). Influence of baseline QTc on sotalol-induced prolongation of ventricular repolarization in men and women. British journal of clinical pharmacology, . https://doi.org/10.1111/bcp.15188
Funck-Brentano, Christian, and Salem, Joe-Elie. "Influence of baseline QTc on sotalol-induced prolongation of ventricular repolarization in men and women." British journal of clinical pharmacology vol. (2021). doi: https://doi.org/10.1111/bcp.15188
Funck-Brentano C, Salem JE. Influence of baseline QTc on sotalol-induced prolongation of ventricular repolarization in men and women. Br J Clin Pharmacol. 2021 Dec 17; doi: 10.1111/bcp.15188. Epub 2021 Dec 17. PMID: 34921433.
Copy Download .nbib Format: NLM
Drug therapy in atrial fibrillation management: where do we stand in 2010?.

The journal of Tehran Heart Center

Davoodi G, Montazeri M.
PMID: 23074588
J Tehran Heart Cent. 2010;5(4):172-8. Epub 2010 Sep 30.

Atrial fibrillation (AF) is a commonly encountered arrhythmia in our daily practice. Every year a huge bulk of data is published about different management strategies, new antiarrhythmic drugs, anticoagulation protocols and ablation procedures in these patients. In this review...

Cite
Davoodi G, Montazeri M. Drug therapy in atrial fibrillation management: where do we stand in 2010?. J Tehran Heart Cent. 2010;5(4):172-8
Davoodi, G., & Montazeri, M. (2010). Drug therapy in atrial fibrillation management: where do we stand in 2010?. The journal of Tehran Heart Center, 5(4), 172-8.
Davoodi, Gholamreza, and Montazeri, Mehdi. "Drug therapy in atrial fibrillation management: where do we stand in 2010?." The journal of Tehran Heart Center vol. 5,4 (2010): 172-8.
Davoodi G, Montazeri M. Drug therapy in atrial fibrillation management: where do we stand in 2010?. J Tehran Heart Cent. 2010;5(4):172-8. Epub 2010 Sep 30. PMID: 23074588; PMCID: PMC3466855.
Copy Download .nbib Format: NLM
Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?.

Frontiers in physiology

Lane JD, Tinker A.
PMID: 29163223
Front Physiol. 2017 Nov 06;8:890. doi: 10.3389/fphys.2017.00890. eCollection 2017.

Anti-arrhythmic drugs are a mainstay in the management of symptoms related to arrhythmias, and are adjuncts in prevention and treatment of life-threatening ventricular arrhythmias. However, they also have the potential for pro-arrhythmia and thus the prediction of arrhythmia predisposition...

Cite
Lane JD, Tinker A. Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?. Front Physiol. 2017;8:890doi: 10.3389/fphys.2017.00890.
Lane, J. D., & Tinker, A. (2017). Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?. Frontiers in physiology, 8890. https://doi.org/10.3389/fphys.2017.00890
Lane, Jem D, and Tinker, Andrew. "Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?." Frontiers in physiology vol. 8 (2017): 890. doi: https://doi.org/10.3389/fphys.2017.00890
Lane JD, Tinker A. Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?. Front Physiol. 2017 Nov 06;8:890. doi: 10.3389/fphys.2017.00890. eCollection 2017. PMID: 29163223; PMCID: PMC5681497.
Copy Download .nbib Format: NLM
Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation.

Pharmacy practice

Wang A.
PMID: 24155819
Pharm Pract (Granada). 2012 Apr;10(2):65-71. doi: 10.4321/s1886-36552012000200001. Epub 2012 Jun 30.

UNLABELLED: Atrial fibrillation is a common cardiac arrhythmia, and has been a significant financial burden. Class III antiarrhythmics such as dofetilide, ibutilide, and amiodarone are indicated for rhythm control. Magnesium may possess intrinsic antiarrhythmic properties, and may potentially increase...

Cite
Wang A. Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation. Pharm Pract (Granada). 2012;10(2):65-71doi: 10.4321/s1886-36552012000200001.
Wang, A. (2012). Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation. Pharmacy practice, 10(2), 65-71. https://doi.org/10.4321/s1886-36552012000200001
Wang, Amy. "Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation." Pharmacy practice vol. 10,2 (2012): 65-71. doi: https://doi.org/10.4321/s1886-36552012000200001
Wang A. Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation. Pharm Pract (Granada). 2012 Apr;10(2):65-71. doi: 10.4321/s1886-36552012000200001. Epub 2012 Jun 30. PMID: 24155819; PMCID: PMC3780486.
Copy Download .nbib Format: NLM
The Impact of Perioperative Use of a Statin-Magnesium Combination on Opioid Consumption in Patients Who Underwent Cardiac Surgery: A Retrospective Study with Propensity-Score Matching.

Chonnam medical journal

Lee C, So CH.
PMID: 32509560
Chonnam Med J. 2020 May;56(2):130-135. doi: 10.4068/cmj.2020.56.2.130. Epub 2020 May 25.

Both statins and magnesium are associated with NMDA receptors and anti-inflammatory effect. Peripheral NMDA receptors are known to be involved in inflammation-induced pain. This study aimed to investigate the impact of perioperative use of a statin-magnesium combination on opioid...

Cite
Lee C, So CH. The Impact of Perioperative Use of a Statin-Magnesium Combination on Opioid Consumption in Patients Who Underwent Cardiac Surgery: A Retrospective Study with Propensity-Score Matching. Chonnam Med J. 2020;56(2):130-135doi: 10.4068/cmj.2020.56.2.130.
Lee, C., & So, C. H. (2020). The Impact of Perioperative Use of a Statin-Magnesium Combination on Opioid Consumption in Patients Who Underwent Cardiac Surgery: A Retrospective Study with Propensity-Score Matching. Chonnam medical journal, 56(2), 130-135. https://doi.org/10.4068/cmj.2020.56.2.130
Lee, Cheol, and So, Cheol Hwan. "The Impact of Perioperative Use of a Statin-Magnesium Combination on Opioid Consumption in Patients Who Underwent Cardiac Surgery: A Retrospective Study with Propensity-Score Matching." Chonnam medical journal vol. 56,2 (2020): 130-135. doi: https://doi.org/10.4068/cmj.2020.56.2.130
Lee C, So CH. The Impact of Perioperative Use of a Statin-Magnesium Combination on Opioid Consumption in Patients Who Underwent Cardiac Surgery: A Retrospective Study with Propensity-Score Matching. Chonnam Med J. 2020 May;56(2):130-135. doi: 10.4068/cmj.2020.56.2.130. Epub 2020 May 25. PMID: 32509560; PMCID: PMC7250675.
Copy Download .nbib Format: NLM
Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.

Circulation

Rillig A, Magnussen C, Ozga AK, Suling A, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Gulizia M, Haegeli L, Heidbuchel H, Kuck KH, Ng A, Szumowski L, van Gelder I, Wegscheider K, Kirchhof P.
PMID: 34328366
Circulation. 2021 Sep 14;144(11):845-858. doi: 10.1161/CIRCULATIONAHA.121.056323. Epub 2021 Jul 30.

BACKGROUND: Even on optimal therapy, many patients with heart failure and atrial fibrillation experience cardiovascular complications. Additional treatments are needed to reduce these events, especially in patients with heart failure and preserved left ventricular ejection fraction.METHODS: This prespecified subanalysis...

Cite
Rillig A, Magnussen C, Ozga AK, et al. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure. Circulation. 2021;144(11):845-858doi: 10.1161/CIRCULATIONAHA.121.056323.
Rillig, A., Magnussen, C., Ozga, A. K., Suling, A., Brandes, A., Breithardt, G., Camm, A. J., Crijns, H. J. G. M., Eckardt, L., Elvan, A., Goette, A., Gulizia, M., Haegeli, L., Heidbuchel, H., Kuck, K. H., Ng, A., Szumowski, L., van Gelder, I., Wegscheider, K., & Kirchhof, P. (2021). Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure. Circulation, 144(11), 845-858. https://doi.org/10.1161/CIRCULATIONAHA.121.056323
Rillig, Andreas, et al. "Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure." Circulation vol. 144,11 (2021): 845-858. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056323
Rillig A, Magnussen C, Ozga AK, Suling A, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Gulizia M, Haegeli L, Heidbuchel H, Kuck KH, Ng A, Szumowski L, van Gelder I, Wegscheider K, Kirchhof P. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure. Circulation. 2021 Sep 14;144(11):845-858. doi: 10.1161/CIRCULATIONAHA.121.056323. Epub 2021 Jul 30. PMID: 34328366; PMCID: PMC8456351.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries